BN-81674

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBN-81674
Drug Alias NameBN-81674
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 3 agonists
TargetsSomatostatin receptor 3
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut Henri Beaufour
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut Henri Beaufour
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A